Abstract
Cancer survivors represent the largest cohort of patients seeking specialty rehabilitative care. They carry a heavy burden of cardiopulmonary complications, but in the past have been excluded from many exercise studies, owing to perceived increased risk. Cardiopulmonary dysfunction in cancer survivors is a complex phenomenon that goes beyond lung volume loss, dilated cardiomyopathy, or accelerated coronary artery disease. All training modalities have been explored in cancer survivors before, during, and after active treatment, proving effective against aerobic capacity decline due to cancer. We summarize common adverse treatment effects, particularly due to newer chemotherapeutic agents, and provide examples of exercise interventions, designed to mitigate cardiopulmonary decline in a cancer survivor. Carefully designed routines can be safely applied in most situations, where aerobic reconditioning is needed. Lastly, physiatrists may be the most effective advocates in overcoming systemic barriers, such as insurance regulations, that limit access to cardiopulmonary rehabilitation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Current Physical Medicine and Rehabilitation Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
